![glp-1 inhibitors Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-023-06057-5/MediaObjects/125_2023_6057_Figa_HTML.png)
glp-1 inhibitors Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]
USD28.08
USD58.08
Pay in 4 interest-free payments of $7.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
![glp-1 inhibitors Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![glp-1 inhibitors Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://i0.wp.com/post.healthline.com/wp-content/uploads/2023/03/male-with-injector-pen-732-549-header.jpg?w=1155&h=1528)
![glp-1 inhibitors Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/299415845/figure/fig2/AS:1086551387844629@1636065446780/GLP-1-based-therapies-including-GLP-1-GLP-1R-agonists-and-DPP-4-inhibitors-have.jpg)
![glp-1 inhibitors Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia glp-1_analogs [TUSOM | Pharmwiki]](https://revolutionhealth.org/cdn/shop/articles/GLP-1_comparison_for_weight_loss.png?v=1769219496)
